Study of Influenza Vaccines Containing an Additional H3 Antigen in Healthy Adult Participants 18 to 49 Years of Age and 60 Years of Age and Older

NCT06507553 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

400

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza
Healthy Volunteers

Interventions

BIOLOGICAL: Trivalent-Darwin influenza vaccine
BIOLOGICAL: Augment-Tasmania influenza vaccine
BIOLOGICAL: TIV-2X Darwin influenza vaccine
BIOLOGICAL: Trivalent-Tasmania influenza vaccine

Sponsor

Sanofi Pasteur, a Sanofi Company